Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

162 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Risk of acute myeloid leukemia and myelodysplastic syndrome in trials of adjuvant epirubicin for early breast cancer: correlation with doses of epirubicin and cyclophosphamide.
Praga C, Bergh J, Bliss J, Bonneterre J, Cesana B, Coombes RC, Fargeot P, Folin A, Fumoleau P, Giuliani R, Kerbrat P, Hery M, Nilsson J, Onida F, Piccart M, Shepherd L, Therasse P, Wils J, Rogers D. Praga C, et al. Among authors: hery m. J Clin Oncol. 2005 Jun 20;23(18):4179-91. doi: 10.1200/JCO.2005.05.029. J Clin Oncol. 2005. PMID: 15961765
Postmenopausal patients with node-positive resectable breast cancer. Tamoxifen vs FEC 50 (6 cycles) vs FEC 50 (6 cycles) plus tamoxifen vs control--preliminary results of a 4-arm randomised trial. The French Adjuvant Study Group.
Gérard JP, Héry M, Gedouin D, Monnier A, Goudier MJ, Jacquin JP, Plat F, Cabarrot E, Serin D, Namer M, et al. Gérard JP, et al. Among authors: hery m. Drugs. 1993;45 Suppl 2:60-7. doi: 10.2165/00003495-199300452-00010. Drugs. 1993. PMID: 7693424 Clinical Trial.
Radiotherapy for invasive breast cancer: guidelines for clinical practice from the French expert review board of Nice/Saint-Paul de Vence.
Belkacémi Y, Fourquet A, Cutuli B, Bourgier C, Hery M, Ganem G, Marsiglia H, Namer M, Gligorov J, Azria D; French Expert Review Board of Nice/Saint-Paul de Vence. Belkacémi Y, et al. Among authors: hery m. Crit Rev Oncol Hematol. 2011 Aug;79(2):91-102. doi: 10.1016/j.critrevonc.2010.06.002. Epub 2010 Jul 7. Crit Rev Oncol Hematol. 2011. PMID: 20615725
162 results